Trial Profile
Comparison of the pharmacokinetics of methylphenidate administered as methylphenidate transdermal system and osmotic-release oral system methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Shire
- 10 Jan 2011 New trial record